RAPID VIROLOGICAL RESPONSE(RVR) VS IL28B CC GENOTYPE IN HCV-1 INFECTED PATIENTS TREATED WITH AN INDIVIDUALIZED COURSE OF PEGINTERFERON (PEGIFN) AND WEIGHT BASED RIBAVRIN (RBV)

被引：0
|
作者：
Mangia, Alessandra [1 ]
Thompson, Alexander J. [2 ]
Santoro, Rosanna [1 ]
Mottola, Leonardo [1 ]
Piazzolla, Valeria [1 ]
Petruzzellis, Daniela [1 ]
Minerva, Nicola [3 ]
Bacca, Donato [4 ]
Goldstein, David B. [5 ]
McHutchison, John G. [2 ]
机构：
[1] IRCCS, Liver Unit, San Giovanni Rotondo, Italy
[2] Duke Clin Res Inst, Durham, NC USA
[3] Hosp Canosa, Canosa, Italy
[4] F Ferrari Hosp, Casarano, Italy
[5] Duke Univ, Ctr Human Genome Variat, Inst Genome Sci & Policy, Durham, NC USA
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
897
引用
收藏
页码：750A / 751A
页数：2
相关论文
共 46 条
  • [1] Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC Patients
    Aghemo, Alessio
    Degasperi, Elisabetta
    Rumi, Maria Grazia
    Galmozzi, Enrico
    Valenti, Luca
    De Francesco, Raffaele
    De Nicola, Stella
    Cheroni, Cristina
    Grassi, Eleonora
    Colombo, Andmassimo
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [2] LOW RATES OF SVR TO PEGINTERFERON PLUS RIBAVIRIN IN HCV GENOTYPE 1 IL28B RS12979860 CC CIRRHOTIC PATIENTS WITHOUT RAPID VIROLOGICAL RESPONSE
    Degasperi, E.
    Aghemo, A.
    Galmozzi, E.
    Valenti, L.
    Rumi, M. G.
    De Francesco, R.
    De Nicola, S.
    Soffredini, R.
    Colombo, M.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S425 - S425
  • [3] HCV GENOTYPE 3 AND SUBTYPE 1B, BUT NOT 1A, ARE INDEPENDENT PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE TO PEGIFN-RBV IN HCV/HIV-COINFECTED PATIENTS WITH UNFAVOURABLE IL28B VARIANTS
    Tellez, Maria
    Vispo, Eugenia
    Aguirrebengoa, Koldo
    Barreiro, Pablo
    Maria Guardiola, Jose
    Martinez, Elisa
    Marino, Ana
    Gomez Sirvent, Juan Luis
    Castro, Angeles
    Bonet, Lucia
    Torres, Rafael
    Benito, Jose M.
    Neukam, Karin
    Morello, Judith
    Matarranz, Mariano
    Martin-Carbonero, Luz
    Jose Rios, Maria
    Soriano, Vincent
    HEPATOLOGY, 2011, 54 : 824A - 824A
  • [4] Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4
    Domagalski, Krzysztof
    Pawlowska, Magorzata
    Tretyn, Andrzej
    Halota, Waldemar
    Tyczyno, Magorzata
    Kozielewicz, Dorota
    Dybowska, Dorota
    HEPATITIS MONTHLY, 2013, 13 (11)
  • [5] Sustained Virological Response After 4 Weeks of Telaprevir, Peginterferon, and Ribavirin in an Asian Patient with Genotype 1 Chronic Hepatitis C and IL28B Genotype CC
    Natalie Brulotte
    Hejin Hahn
    Maximilian Lee
    Digestive Diseases and Sciences, 2014, 59 : 737 - 739
  • [6] Sustained Virological Response After 4 Weeks of Telaprevir, Peginterferon, and Ribavirin in an Asian Patient with Genotype 1 Chronic Hepatitis C and IL28B Genotype CC
    Brulotte, Natalie
    Hahn, Hejin
    Lee, Maximilian
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (04) : 737 - 739
  • [7] COMPLETELY INDIVIDUALIZED TREATMENT DURATIONS WITH PEGINTERFERON-ALFA-2B AND RIBAVIRIN IN HCV GENOTYPE 1-INFECTED PATIENTS AND IMPORTANCE OF IL28B GENOTYPE (INDIV-2 STUDY)
    Sarrazin, Christoph
    Schwendy, Susanne
    Moeller, Bernd
    Dikopoulos, Nektarios
    Buggisch, Peter
    Encke, Jens
    Teuber, Gerlinde
    Goeser, Tobias
    Thimme, Robert
    Klinker, Hartwig
    Boecher, Wulf O.
    Schulte-Frohlinde, Ewert
    Prinzing, Renate
    Berg, Thomas
    Zeuzem, Stefan
    HEPATOLOGY, 2010, 52 (04) : 384A - 384A
  • [8] Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes
    Torres-Cornejo, A.
    Ruiz-Valderas, R.
    Jimenez-Jimenez, L.
    Abad-Molina, C.
    Gutierrez-Valencia, A.
    Viciana, P.
    Lopez-Cortes, L. F.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (03) : 178 - 188
  • [9] CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV
    Lin, Chia-Chen
    Su, Shih-Huan
    Jeng, Wen-Juei
    Huang, Chien-Hao
    Teng, Wei
    Chen, Wei-Ting
    Chen, Yi-Cheng
    Lin, Chun-Yen
    Sheen, I-Shyan
    BMC GASTROENTEROLOGY, 2017, 17
  • [10] CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV
    Chia-Chen Lin
    Shih-Huan Su
    Wen-Juei Jeng
    Chien-Hao Huang
    Wei Teng
    Wei-Ting Chen
    Yi-Cheng Chen
    Chun-Yen Lin
    I-Shyan Sheen
    BMC Gastroenterology, 17
12345